Skip to main content
SpringerLink
Log in

Neurologic Complications of Hematopoietic Stem Cell Transplantation

  • Chapter
Cancer Neurology in Clinical Practice

Abstract

Bone marrow (hematopoietic stem cell) transplantation (BMT or HSCT) can be broadly defined as infusion of bone marrow or peripheral blood cells in a properly prepared (conditioned) patient. It is estimated that annually 30,000–40,000 HSCT are performed worldwide due to better availability of suitable donors. Some of the indications are well defined and more widely accepted. HSCT is now a common procedure to treat hematologic malignant disorders thought to be largely incurable. HSCT also has potential use for a number of solid neoplasms and non-neoplastic disorders (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thomas ED, Blume KG, Forman SJ. Hematopoietic Cell Transplantation, 2nd ed. Blackwell Science Inc., Malden, MA, 1999.

    Google Scholar 

  2. Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D, et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 1998; 21: 537–541.

    Article  PubMed  CAS  Google Scholar 

  3. Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, et al. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. Blood 1998; 92: 3505–3514.

    PubMed  CAS  Google Scholar 

  4. Cohen BA, Karlin KH, Lobeck L, Russell E, Davis F, Stefoski D, Burns W, Burt RK. Intense immune ablative therapy with autologous hematopoietic stem cell rescue for progressive multiple sclerosis: a pilot safety study. Neurology 2000; 54: 59 (abstract).

    Google Scholar 

  5. Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V, Tsompanakou A. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997; 20: 631–638.

    Article  PubMed  CAS  Google Scholar 

  6. Kozak T, Havrdova E, Pit’ha J, Gregora E, Pytlik R, Maaloufova J, et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple scleroris. Bone Marrow Transplant 2000; 25: 525–531.

    Article  PubMed  CAS  Google Scholar 

  7. Gertz MA, Lacy MQ, Dispenzieri A. Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report. Bone Marrow Transplant 2000; 25: 465–470.

    Article  PubMed  CAS  Google Scholar 

  8. Gertz MA, Lacy MQ, Gasstineau DA, Inwards DJ, Chen MG, Tefferi A, et al. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL). Bone Marrow Transplant 2000; 26: 963–969.

    Article  PubMed  CAS  Google Scholar 

  9. Fine HA, Antman KB. High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience. Bone Marrow Transplant 1992; 10: 315–321.

    PubMed  CAS  Google Scholar 

  10. Gururangan S, Dunkel I, Goldman S, et al. Myeloablative chemotherapy with autologous bone marrow rescue for patients with recurrent malignant brain tumors. J Clin Oncol 1998; 16: 2486 2493.

    Google Scholar 

  11. Millot F, Delval O, Giraud C, Bataille B, Babin P, Germain T, et al. High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two cases. Bone Marrow Transplant 1999; 24: 1347–1349.

    Article  PubMed  CAS  Google Scholar 

  12. Staba M-J, Goldman S, Johnson FL, Huttenlocher PR. Allogeneic bone marrow transplantation for Alexander’s disease. Bone Marrow Transplant 1997; 20: 247–249.

    Article  PubMed  CAS  Google Scholar 

  13. Mahmood A, Lu D, Yi L, Chen JL, Chopp M. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg 2001; 94: 589–595.

    Article  PubMed  CAS  Google Scholar 

  14. Forman SJ, Openshaw H. Bone marrow (hematopoietic cell) transplantation. In: Neurologic Complications in Organ Transplant Recipients. Wijdicks EFM, ed. Butterworth-Heinemann, Boston, 1999.

    Google Scholar 

  15. Snider S, Bashir R, Bierman P. Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin’s disease. Neurology 1994; 44: 681–684.

    Article  PubMed  CAS  Google Scholar 

  16. Gallardo D, Ferra C, Berlanga JJ, de la Banda E, Ponce C, Salar A, et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1135–1139.

    PubMed  CAS  Google Scholar 

  17. Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Carreras E, Tolosa E, Rozman C Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996; 46: 1004–1009.

    Article  PubMed  CAS  Google Scholar 

  18. Antonini G, Ceschin V, Morino S, Fiorelli M, Gragnani F, Mengarelli A, Iori AP, Arcese W. Early neurologic complications following allogeneic bone marrow transplant for leukemia. Neurology 1998; 50: 1441–1445.

    Article  PubMed  CAS  Google Scholar 

  19. den Brabander C, Cornelissen J, Sillevis Smitt PAE, Vecht ChJ, van den Bent MJ. Increased incidence of neurological complications in patients receiving allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 2000; 68: 36–40.

    Article  PubMed  Google Scholar 

  20. Patchell RA, White III CL, Clark AW, Beschorner WE, Santos GW. Neurologic complications of bone marrow transplantation. Neurology 1985; 35: 300–306.

    Article  PubMed  CAS  Google Scholar 

  21. Mohrmann RL, Mah V, Vinters HV. Neuropathologie findings after bone marrow transplantation: an autopsy study. Hum Pathol 1990; 21: 630–639.

    Article  PubMed  CAS  Google Scholar 

  22. Bleggi-Torres LF, de Medeiros BC, Werner B, Zanis Neto J, Loddo G, Pasquini R, de Medeiros CR. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 2000; 25: 301–307.

    Article  PubMed  CAS  Google Scholar 

  23. Gordon B, Lyden E, Lynch J, Tarantolo S, Pavletie ZS, Bishop M, et al. Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients. Bone Marrow Transplant 2000; 25: 79–83.

    Article  PubMed  CAS  Google Scholar 

  24. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE, et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697–704.

    Article  PubMed  CAS  Google Scholar 

  25. Baker WJ, Royer GL, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol 1991; 9: 679–693.

    PubMed  CAS  Google Scholar 

  26. de La Camara R, Tomas JF, Figuera A, Berberana M, Fernandez Ranada JM. High dose busulfan and seizures. Bone Marrow Transplant 1991; 7: 363–364.

    Google Scholar 

  27. Openshaw H, Slatkin NE. Differential diagnosis of neurological complications in bone marrow transplantation. The Neurologist 1995; 1: 191–206.

    Google Scholar 

  28. Ebner F, Ranner G, Slave I, Urban Ch, Kleinert R, Radner H, Einspieler R, Justich E. MR findings in methotrexate-induced CNS abnormalities. Am J Neuroradiol 1989; 10: 959–964.

    PubMed  CAS  Google Scholar 

  29. Sullivan KM, Storb R, Shulman HM, Shaw C-M, Spence A, Beckham C, et al. Immediate and delayed neurotoxicity after mechlorethamine preparation for bone marrow transplantation. Ann Int Med 1982; 97: 182–189.

    Article  PubMed  CAS  Google Scholar 

  30. Anderson NR, Tandon DS. Ifosfamide extrapyramidal neurotoxicity. Cancer 1991; 68: 72–75.

    Article  PubMed  CAS  Google Scholar 

  31. Meanwell CA, Blake AE, Kelly KA, Honigsberger L, Blackledge G. Prediction of ifosfamide/mesna associated encephalopathy. Eur J Cancer Clin Oncol 1986; 22: 815–819.

    Article  PubMed  CAS  Google Scholar 

  32. Curtin JP, Koonings PP, Gutierrez M, Schlaerth JB, Morrow CP. Ifosfamide-induced neurotoxicity. Gynecolog Oncol 1991; 42: 193–196.

    Article  CAS  Google Scholar 

  33. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255–267.

    Article  PubMed  CAS  Google Scholar 

  34. Rabinowe SN, Soiffer RJ, Tarell NJ, Neuberg D, Freedman AS, Seifter J, et al. Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991; 77: 1837–1844.

    PubMed  CAS  Google Scholar 

  35. Guinan EC, Tarbell NJ, Niemeyer CM, Sallan SE, Weinstein HJ. Intravascular hemolysis and renal insufficiency after bone marrow transplantation. Blood 1988; 72: 451–455.

    PubMed  CAS  Google Scholar 

  36. Haire WD. The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation. Semin Thromb Hemost 1999; 25: 223–237.

    Article  PubMed  CAS  Google Scholar 

  37. Colosimo M, McCarthy N, Jayasinghe R, Morton J, Taylor K, Durrant S. Diagnosis and management of subdural haematoma complicating marrow transplantation. Bone Marrow Transplant 2000; 25: 549–552.

    Article  PubMed  CAS  Google Scholar 

  38. Pomeranz S, NaparstekE, Ashkenazi E, Nagler A, Lossos A, Slavin S, Or R. Intracranial haematomas following bone marrow transplantation. J Neurol 1994; 241: 252–256.

    Article  PubMed  CAS  Google Scholar 

  39. Harvey CJ, Peniket M, Miszkiel K, Patterson K, Goldstone AH, Mackinnon S, Hall-Craggs MA. MR angiographic diagnosis of cerebral venous sinus thrombosis following allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 25: 791–795.

    Article  PubMed  CAS  Google Scholar 

  40. Bertz H, Laubenberger J, Steinfurth G, Finke J. Sinus venous thrombosis: an unusual cause for neurologic symptoms after bone marrow transplantation under immunosuppression. Transplantation 1998; 66: 241–244.

    Article  PubMed  CAS  Google Scholar 

  41. Mori A, Tanaka J, Kobayashi S, Hashino S, Yamamoto Y, Ota S, et al. Fatal cerebral hemorrhage associated with cyclosporin-A/ FK506-related encephalopathy after allogeneic bone marrow transplantation. Ann Hematol 2000; 79: 588–592.

    Article  PubMed  CAS  Google Scholar 

  42. Gordon BG, Saving Kl, McCallister JA, Warkentin PI, McConnell JR, Roberts WM, et al. Cerebral infarction associated with protein >C deficiency following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 323–325

    Google Scholar 

  43. Gordon B, Haire W, Kessinger A, Duggan M, Armitage J. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1991; 8: 497–502.

    PubMed  CAS  Google Scholar 

  44. Kaufman PA, Jones RB, Greenberg CS, Peters WP. Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Cancer 1990; 66: 515–521.

    Article  PubMed  CAS  Google Scholar 

  45. Qasim W, Gerritsen B, Veys P. Anticardiolipin antibodies and thromboembolism after BMT. Bone Marrow Transplant 1998; 21: 845–847.

    Article  PubMed  CAS  Google Scholar 

  46. Richard S, Seigneur M, Blann A, Adams R, Renard M, Puntous M, et al. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1996; 18: 955959.

    Google Scholar 

  47. Kalhs P, Bragger S, Schwarzinger I, Greinix HT, Keil F, Kyrie PA, et al. Microangiopathy following allogeneic marrow transplantation. Transplantation 1995; 60: 949–957.

    PubMed  CAS  Google Scholar 

  48. Jerman MR, Fick RB Jr. Nonbacterial thrombotic endocarditis associated with bone marrow transplanation. Chest 1986; 90: 919–922.

    Article  PubMed  CAS  Google Scholar 

  49. Patchell RA, White III CL, Clark AW, Beschorner WE, Santos GW. Nonbacterial thrombotic endocarditis in bone marrow transplant patients. Cancer 1985; 55: 631–635.

    Article  PubMed  CAS  Google Scholar 

  50. Tschuchnigg M, Bradstock KF, Koutts J, Stewart J, Enno A, Seldon M. A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation. Bone Marrow Transplant 1990; 5: 61–63.

    PubMed  CAS  Google Scholar 

  51. Padovan CS, Bise K, Hahn J, Sostak P, Holler E, Kolb H-J, Straube A. Angiitis of the central nervous system after allogeneic bone marrow transplantation? Stroke 1999; 30: 1651–1656.

    Article  PubMed  CAS  Google Scholar 

  52. Walters MC, Patience M, Leisenring W, Eckman JR, Scott P, Mentzer WC, et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369–376.

    Article  PubMed  CAS  Google Scholar 

  53. Wszolek ZK, Steg RE, Armitage JO. Complex partial status epilepticus after bone marrow transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplant 1997; 19: 637–638.

    Article  PubMed  CAS  Google Scholar 

  54. Penn J. De novo malignant lesions of the central nervous system. In: Neurologic Complications in Organ Transplant Recipients. Wijdicks EFM, ed. Butterworth-Heinemann, Boston, 1999.

    Google Scholar 

  55. Kolb HJ, Bender-Gotze Ch. Late complications after allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1990; 6: 61–72.

    PubMed  CAS  Google Scholar 

  56. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784–789.

    Article  PubMed  CAS  Google Scholar 

  57. Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348–357.

    PubMed  CAS  Google Scholar 

  58. Kulkarni S, Powles R, Treleaven J, Singhai S, Horton C, Sirohi B, et al. Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 years. Bone Marrow Transplant 2000; 25: 365–370.

    Article  PubMed  CAS  Google Scholar 

  59. Shah AK. Cyclosporine A neurotoxicity among bone marrow transplant recipients. Clin Neuropharmacol 1999; 22: 67–73.

    Article  PubMed  CAS  Google Scholar 

  60. Steg RE, Kessinger A, Wszolek ZK. Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 959–962.

    Article  PubMed  CAS  Google Scholar 

  61. Memon M, deMagalhaes-Silverman M, Bloom EJ, Lister J, Myers DJ, Pincus SM, et al. Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1995; 15: 283–286.

    PubMed  CAS  Google Scholar 

  62. Tsuji A, Tamai I, Sakata A, Tenda Y, Terasaki T. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem Pharmacol 1993; 46: 1096–1099.

    Article  PubMed  CAS  Google Scholar 

  63. Wijdicks EFM. Neurologic Complications of Critical Illness, 2nd ed. Oxford University Press, New York, 2002.

    Google Scholar 

  64. Coley SC, Porter DA, Calamante F, Chong WK, Connelly A. Quantitative MR diffusion mapping and cyclosporin-induced neurotoxicity. AJNR Am J Neuroradiol 1999; 8: 1507–1510.

    Google Scholar 

  65. Cordon-Cardo C, O’Brien JP, Casals D, Rittman-Grauer L, Bielder JL, Melamed MR, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695–698.

    Article  PubMed  CAS  Google Scholar 

  66. Debaere C, Stadnik T, De Maeseneer M, Osteaux M. Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema. Eur Radio! 1999; 9: 1916–1918.

    Article  CAS  Google Scholar 

  67. Guerini D. Calcineurin: not just a simple protein phosphatase. Biochem Biophys Res Commun 1997; 235: 271–275.

    Article  PubMed  CAS  Google Scholar 

  68. McDonald JW, Goldberg MP, Gwag BJ, Chi SI, Choi SW. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures. Ann Neurol 1996; 40: 750–758.

    Article  PubMed  CAS  Google Scholar 

  69. Takeguchi N, Ichimura K, Koike M, Matsui W, Kashiwagura T, Kawahara K. Inhibition of the multidrug efflux pump in isolated hepatocyte couplets by immunosuppresants FK506 and cyclosporine. Transplantation 1993; 3: 646–650.

    Article  Google Scholar 

  70. Truwit CL, Denaro CP, Lake JR, DeMarco. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991; 12: 651–659.

    PubMed  CAS  Google Scholar 

  71. Jarosz JM, Howlett DC, Cox TCS, Bingham JB. Cyclosporinerelated reversible posterior leukoencephalopathy: MRI. Neuroradiol 1997; 39: 711–715.

    Article  CAS  Google Scholar 

  72. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Int Med 1984; 101: 92–104.

    Article  PubMed  CAS  Google Scholar 

  73. Eng RHK, Munsif AN, Yangco BG, Smith SM, Chmel H. Seizure propensity with imipenem. Arch Intern Med 1989; 149: 1881–1883.

    Article  PubMed  CAS  Google Scholar 

  74. Frytak S, Moertel CG, Childs DS, Albers JW. Neurologic toxicity associated with high-dose metronidazole therapy. Ann Int Med 1978; 88: 361–362.

    Article  PubMed  CAS  Google Scholar 

  75. Wade JC, Meyers JD. Neurologic symptoms associated with parenteral acyclovir treatment after marrow transplantation. Ann Intern Med 1983; 98: 921–925.

    Article  PubMed  CAS  Google Scholar 

  76. Swan SK, Bennett WM. Oral acyclovir and neurotoxicity. Ann Intern Med 1989; 111: 188.

    Article  PubMed  CAS  Google Scholar 

  77. Cohen SMZ, Minkove JA, Zebley JW III, Mulholland JH. Severe but reversible neurotoxicity from acyclovir. Ann Intern Med 1984; 100: 920.

    Article  PubMed  CAS  Google Scholar 

  78. Conti DJ, Rubin RH. Infection of the central nervous system in organ transplant recipients. Neurol Clinic 1988; 6: 241–260.

    CAS  Google Scholar 

  79. Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J, Snydman DR. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000; 6: 44–49.

    Article  PubMed  CAS  Google Scholar 

  80. Tauro S, Toh V, Osman H, Mahendra P. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an a11oBMT patient. Bone Marrow Transplant 2000; 26: 795–796.

    Article  PubMed  CAS  Google Scholar 

  81. Dellemijn PL, Brandenburg A, Niesters HG, van den Bent MJ, Rothbarth PH, Vlasveld LT. Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant. Bone Marrow Transplant 1995; 16: 311–312.

    PubMed  CAS  Google Scholar 

  82. Davis D, Henglee PJ, Markesberry WR. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient. Ann Neurol 1988; 23: 385–389.

    Article  PubMed  CAS  Google Scholar 

  83. Abraham J, Bilgrami S, Dorsky D, Edwards RL, Feingold J, Hill DR, Tutschka PJ. Stomatococcus mucilaginosus meningitis in a patient with multiple myeloma following autologous stem cell transplantation. Bone Marrow Transplant 1997; 19: 639–641.

    Article  PubMed  CAS  Google Scholar 

  84. Long SG, Leyland MJ, Milligan DW. Listeria meningitis after bone marrow transplantation. Bone Marrow Transplant 1993; 12: 537–539.

    PubMed  CAS  Google Scholar 

  85. D’Antonio D, Di Bartolomeo P, Iacone A, Olioso P, Di Girolamo G, Angrilli F, et al. Meningitis due to penicillin-resistant Streptococcus pneumoniae in patients with chronic graft-versus-host disease. Bone Marrow Transplant 1992; 9: 299–300.

    PubMed  Google Scholar 

  86. Feingold JM, Abraham J, Bilgrami S, Ngo N, Visvesara GS, Edwards RL, Tutschka PJ. Acanthamoeba meningoencephalitis following autologous peripheral stem cell transplantation. Bone Marrow Transplant 1998; 22: 297–300.

    Article  PubMed  CAS  Google Scholar 

  87. Bosi A, Zazzi M, Amantini A, Cellerini M, Vannucchi AM, De Milito A, et al. Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant Bone Marrow Transplant 1998; 22: 285–288.

    Article  CAS  Google Scholar 

  88. Mookerjee BP, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997; 20: 905–906.

    Article  PubMed  CAS  Google Scholar 

  89. Tsujimura H, Iseki T, Date Y, Watanabe J, Kumagai K, Kikuno K, Yonemitsu H, Saisho H. Human herpesvirus-6 encephalitis after bone marrow transplantation: magnetic resonance imaging could identify the involved sites of encephalitis. Eur J Haematol 1998; 61: 284–285.

    Article  PubMed  CAS  Google Scholar 

  90. Singh N, Paterson DL. Encephalitis caused by human herpesvirus6 in transplant recipients: relevance of a novel neurotropic virus. Transplantion 2000; 69: 2474–2479.

    Article  CAS  Google Scholar 

  91. Lau YL, Peiris M, Chan GCF, Chan ACL, Chiu D, Ha SY. Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion. Bone Marrow Transplant 1998; 21: 1063–1066.

    Article  PubMed  CAS  Google Scholar 

  92. Kimberlin DW, Whitley RJ. Human herpesvirus-6: neurologic implications of a newly-described viral pathogen. J Neurovirol 1998; 4: 474–485.

    Article  PubMed  CAS  Google Scholar 

  93. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 1356 1360.

    Google Scholar 

  94. Wang ‘F-Z, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999; 28: 562–568.

    Article  Google Scholar 

  95. Rogers J, Rohal S, Carrigan DR, Kusne S, Knox KK, Gayowski T, et al. Human herpesvirus-6 in liver transplant recipients. Transplantation 2000; 69: 2566–2573.

    Article  PubMed  CAS  Google Scholar 

  96. Choucino C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS. Nocardial infections in bone marrow transplant recipients. Clin Infect Dis 1996; 23: 1012–1019.

    Article  PubMed  CAS  Google Scholar 

  97. Elliott MA, Tefferi A, Marshall WF, Lacy MQ. Disseminated nocardiosis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997; 20: 425–426.

    Article  PubMed  CAS  Google Scholar 

  98. Tolkoff-Rubin NE, Hoving GK, Rubin RH. Central nervous system infections. In: Neurologic Complications in Organ Transplant Recipients. Wijdicks EFM, ed. Butterworth-Heinemann, Boston, 1999.

    Google Scholar 

  99. Campos A, Vaz CP, Campilho F, Morais A, Guimaraes MA, Lopes C, Portal A, Carvalhais A, Pimentel P. Central nervous system (CNS) tuberculosis following allogeneic stem cell transplantation. Bone Marrow Transplant 2000; 25: 567–569.

    Article  PubMed  CAS  Google Scholar 

  100. Martino R Martinez C, Brunet S, Sureda A, Lopez R, DomingoAlbos A. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996;18:809–812.

    Google Scholar 

  101. Aljurf M, Gyger M, Alrajhi A, Sahovic E, Chaudhri N, Musa M, et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999; 24: 551–554.

    Article  PubMed  CAS  Google Scholar 

  102. Maschke M, Dietrich U, Prumbaum M, Kastrup O, Turowski B, Schaefer UW, Diener HC. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1167–76.

    Article  PubMed  CAS  Google Scholar 

  103. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985; 18: 574–582.

    Article  PubMed  CAS  Google Scholar 

  104. Miaux Y, Ribaud P, Williams M, Guermazi A, Gluckman E, Brocheriou C, Laval-Jeantet M. MR of cerebral aspergillosis in patients who have had bone marrow transplantation. AJNR Am J Neuroradiol. 1995; 16: 555–562.

    PubMed  CAS  Google Scholar 

  105. Khoury H, Adkins D, Miller G, Goodnough L, Brown R, DiPersio J. Resolution of invasive central nervous system a spergillosis in a transplant recipient. Case report. Bone Marrow Transplant 1997; 20: 179–180.

    Article  PubMed  CAS  Google Scholar 

  106. Baslar Z, Soysal T, Hanci M, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient. Bone Marrow Transplant 1998; 22: 404–405.

    Article  PubMed  CAS  Google Scholar 

  107. Verfaillie C, Weisdorf D, Haake R, Hostetter M, Ramsay NC, McGlave P. Candida infections in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 177–184.

    PubMed  CAS  Google Scholar 

  108. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984–1992. Clin Infect Dis 1994; 19: 402–408.

    Article  PubMed  CAS  Google Scholar 

  109. Nenoff P, Kellermann S, Schober R, Nenning H, Kubel M, Winkler J, Haustein UF. Rhinocerebral zygomycosis following bone marrow transplantation in chronic myelogenous leukaemia. Report of a case and review of the literature. Mycoses 1998; 41: 365–372.

    Article  PubMed  CAS  Google Scholar 

  110. Baddley JW, Moser SA, Sutton DA, Pappas PG. Microascus cinereus (Anamorph Scopulariopsis) brain abscess in a bone marrow transplant recipient. J Clin Microbiol 2000; 38: 395–397.

    PubMed  CAS  Google Scholar 

  111. Chandrasekar PH, Momin F, Bone Marrow Transplant Team. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant 1997; 19: 685–689.

    Article  PubMed  CAS  Google Scholar 

  112. Brinkman K, Debast S, Sauerwein R, Ooyman F, Hiel J, Raemaekers J. Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 635–636.

    Article  PubMed  CAS  Google Scholar 

  113. Derouin F, Devergie A, Auber P, Gluckman E, Beauvais B, Garin JF, Lariviere M. Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. Clin Infect Dis 1992; 15: 267–270.

    Article  PubMed  CAS  Google Scholar 

  114. Bretagne S, Costa JM, Kuentz M, Simon D, Vidaud M, Fortel I, et al. Late toxoplasmosis evidenced by PCR in a marrow transplant recipient. Bone Marrow Tranplant 1995; 15: 809–811.

    CAS  Google Scholar 

  115. Tefferi A, O’Neill BP, Inwards DJ. Late-onset cerebral toxoplasmosis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21: 1285–1286.

    Article  PubMed  CAS  Google Scholar 

  116. Dietrich U, Maschke M, Dörfler A, Prumbaum M, Forsting M. MRI of intracranial toxoplasmosis after bone marrow transplantation. Neuroradiology 2000; 42: 14–18.

    Article  PubMed  CAS  Google Scholar 

  117. Löwenberg B, van Gijn J, Prins E, Polderman AM. Fatal cerebral toxoplasmosis in a bone marrow transplant recipient with leukemia. Transplantation 1983; 35: 30–34.

    Article  PubMed  Google Scholar 

  118. Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13: 549–557.

    PubMed  CAS  Google Scholar 

  119. Khoury H, Adkins D, Brown R, Goodnough L, Gokden M, Roberts T, et al. Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection. Bone Marrow Transplant 1999; 23: 409–411.

    Article  PubMed  CAS  Google Scholar 

  120. Seong DC, Przepiorka D, Bruner JM, Van Tassel P, Lo WK, Champlin RE. Leptomeningeal toxoplasmosis after allogeneic marrow transplantation. Am J Clin Oncol (CCT) 1993; 16: 105108.

    Google Scholar 

  121. Cancelas JA, Lopez-Jimenez J, Gonzalez C, Calbo MA, Garcia Larana J. Cerebral toxoplasmosis with atypical presentation in a bone marrow transplant patient. Med Clin (Barc) 1994; 103: 383384.

    Google Scholar 

  122. Bleggi-Torres LF, de Medeiros BC, Werner B, Pasquini R, de Medeiros CR. Unusual presentation of cerebral toxoplasmosis after BMT. Bone Marrow Transplant 1999; 23: 855–856.

    Article  PubMed  CAS  Google Scholar 

  123. Atkinson K, Meyers JD, Storb R, Prentice RL, Thomas ED. Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation 1980; 29: 47–50.

    Article  PubMed  CAS  Google Scholar 

  124. Re D, Bamborschke S, Feiden W, Schroder R, Lehrke R, Diehl V, Tesch H. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant 1999; 23: 295–298.

    Article  PubMed  CAS  Google Scholar 

  125. Coppo P, Laporte JP, Aoudjhane M, Lebon P, Isnard F, Lesage S, Gorin NC, Najman A. Progressive multifocal leucoencephalopathy with peripheral demyelinating neuropathy after autologous bone marrow transplantation for acute myeloblastic leukemia (FAB5). Bone Marrow Transplant 1999; 23: 401–403.

    Article  PubMed  CAS  Google Scholar 

  126. Mesquita R, Parravicin C, Björkholm, Ekman M, Biberfeld P. Macrophage association of polyomavirus in progressive multifocal leukoencephalopathy: an immunohistochemical and ultrastructural study. APMIS 1992; 100: 993–1000.

    Article  PubMed  CAS  Google Scholar 

  127. O’ Shaughnessy D, Goldman JM, Roddie M, Schofield JB. Dizziness and confusion after bone marrow transplantation [clinico-pathological conference]. BMJ 1994; 309: 262–265.

    Article  Google Scholar 

  128. Owen RG, Patmore RD, Smith GM, Barnard DL. Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation. Br J Haematol 1995; 89: 196–198.

    Article  PubMed  CAS  Google Scholar 

  129. Seong D, Bruner JM, Lee KH, Mirza N, Kwon BD, Lee JH, Lee YY, Ro J, Talpaz M, Champlin R, Deisseroth AB. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia. Clin Infect Dis 1996; 23: 402–403.

    Article  PubMed  CAS  Google Scholar 

  130. Przepiorka D, Jaeckle KA, Birdwell RR, Fuller GN, Kumar AJ, Huh YO, McCutcheon I. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant 1997; 20: 983–987.

    Article  PubMed  CAS  Google Scholar 

  131. Tse N, Cederbaum S, Glaspy JA. Hyperammonemia following allogeneic bone marrow transplantation. Am J Hematol 1991; 38: 140–141.

    Article  PubMed  CAS  Google Scholar 

  132. Davies SM, Szabo E, Wagner JE, Ramsay NKC, Weisdorf DJ. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1119–1125.

    PubMed  CAS  Google Scholar 

  133. Mitchell RB, Wagner JE, Karp JE, Watson AJ, Brusilow SW, Przepiorka D, et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med 1988; 85: 662–667.

    Article  PubMed  CAS  Google Scholar 

  134. Sharp RA, Lang CC. Hyperammonaemic encephalopathy in chronic myelomonocytic leukemia. Lancet 1987;i:805 (letter).

    Google Scholar 

  135. Leonard JV, Kay JDS. Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukemia with asparaginase. Lancet 1986;i:162–163 (letter).

    Google Scholar 

  136. Blindauer KA, Harrington G, Morris GL 3rd, Ho KC. Fulminant progression of demyelinating disease after valproate-induced encephalopathy. Neurology 1998; 51: 292–295.

    Article  PubMed  CAS  Google Scholar 

  137. Tahsildar HI, Remler BF, Creger RJ, Cooper BW, Snodgrass SM, Tarr RW, Lazarus HM. Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients. J Neurooncol 1996; 27: 241–250.

    Article  PubMed  CAS  Google Scholar 

  138. Openshaw H, Slatkin NE, Parker PM, Forman SJ. Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant 1995; 15: 63–636.

    Google Scholar 

  139. Chao MWT, Wirth A, Ryan G, MacManus M, Liew KH. Radiation myelopathy following transplantation and radiotherapy for non-Hodgkin’ s lymphoma. IntJ Radiat Oncol Biol Phys 1998; 41: 1057 1061.

    Google Scholar 

  140. Schwartz DL, Schechter GP, Seltzer S, Chauncey TR. Radiation myelitis following allogeneic stem cell transplantation and consolidation radiotherapy for non-Hodgkin’s lymphoma. Bone Marrow Transplant 2000; 26: 1355–1359.

    Article  PubMed  CAS  Google Scholar 

  141. Richard S, Fruchtman S, Scigliano E, Skerrett D, Najfeld V, Isola L. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia. Bone Marrow Transplant 2000; 26: 1225–1228.

    Article  PubMed  CAS  Google Scholar 

  142. Ferrara JLM, Deeg J, Burakoff SJ. Graft-vs-Host Disease, 2nd ed. Book News, Inc., Portland, OR, 1997.

    Google Scholar 

  143. Klingebiel T, Schlegel PG. GVHD: overview on pathophysiology, incidence, clinical and biological features. Bone Marrow Transplant 1998; 21: S45 - S49.

    PubMed  Google Scholar 

  144. Rouah E, Gruber R, Shearer W, Armstrong D, Hawkins EP. Graftversus-host disease in the central nervous system. A real entity? Am J Clin Pathol 1988; 89: 543–546.

    PubMed  CAS  Google Scholar 

  145. Azuno Y, Yaga K, Kaneko T, Kaku K, Oka Y. Chronic graftversus-host disease and seizure. Blood 1998; 91: 2626–2628.

    PubMed  CAS  Google Scholar 

  146. Majolino I, Caponetto A, Scime R, Vasta S, Fabbiano F, Carona F. Wernicke-like encephalopathy after autologous bone marrow transplantation. Haematologica 1990; 75: 282–284.

    PubMed  CAS  Google Scholar 

  147. Bleggi-Torres LF, de Medeiros BC, Ogasawara VSA, Loddo G, Zanis Neto J, Pasquini R, de Medeiros CR. Iatrogenic Wernicke’ s encephalopathy in allogeneic bone marrow transplantation: a study of eight cases. Bone Marrow Transplant 1997; 20: 391–395.

    Article  PubMed  CAS  Google Scholar 

  148. Gabriel CM, Goldman JM, Lucas S, Hughes RAC. Vasculitic neuropathy in association with chronic graft-versus-host disease. J Neurol Sci 1999; 168: 68–70.

    Article  PubMed  CAS  Google Scholar 

  149. Bolton CF, Young GB. Critical illness polyneuropathy. Current treatment options in neurology 2000; 2: 489–498.

    Article  PubMed  Google Scholar 

  150. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve 2000; 999: S49 - S52.

    Article  Google Scholar 

  151. Openshaw H. Peripheral neuropathy after bone marrow transplantation. Biol Blood Marrow Transplant 1997; 3: 202–209.

    PubMed  CAS  Google Scholar 

  152. Wen PY, Aleya EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barré syndrome following allogeneic bone marrow transplantation. Neurology 1997; 49: 1711–1714.

    Article  PubMed  CAS  Google Scholar 

  153. Roskrow MA, Kelsey SM, McCarthy M, Newland AC, Monson JP. Selective autonomic neuropathy as a novel complication of BMT. Bone Marrow Transplant 1992; 10: 469–470.

    PubMed  CAS  Google Scholar 

  154. Greenspan A, Deeg HG, Cottler-Fox M, Sirdofski M, Spitzer TR, Kattah J. Incapacitating peripheral neuropathy as a manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 1990; 5: 349–352.

    PubMed  CAS  Google Scholar 

  155. Amato AA, Barohn RJ, Sahenk Z, Tutschka PJ, Mendell JR. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993; 43: 1513–1518.

    Article  PubMed  CAS  Google Scholar 

  156. Griggs JJ, Commichau CS, Rapoport AP, Griggs RC. Chronic inflammatory demyelinating polyneuropathy in non-Hodgkin’ s lymphoma. Case Report. Am J Hematol 1997; 54: 332–334.

    Article  PubMed  CAS  Google Scholar 

  157. Bolger GB, Sullivan KM, Spence AM, Appelbaum FR, Johnston R, Sanders JE, et al. Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease. Neurology 1986; 36: 1087–1091.

    Article  PubMed  CAS  Google Scholar 

  158. Parker P, Chao NJ, Ben-Ezra J, Slatkin N, Openshaw H, Niland JC, et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine 1996; 75: 279–285.

    Article  PubMed  CAS  Google Scholar 

  159. Tse S, Saunders EF, Silverman E, Vajsar J, Becker L, Meaney B. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host disease. Bone Marrow Transplant 1999; 23: 397399.

    Google Scholar 

  160. Baron F, Sadzot B, Wang F, Beguin Y. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 197–200.

    Article  PubMed  CAS  Google Scholar 

  161. Zaja F, Russo D, Fuga G, Perella G, Baccarani M. Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology 2000; 55: 1062–1063.

    Article  PubMed  CAS  Google Scholar 

  162. Zaja F, Russo D, Silvestri F, Barillari G, Fanin R, Cerno M, Marchini C, Baccarani M. Myasthenia gravis after allogeneic bone marrow transplantation: a case report. Bone Marrow Transplant 1995; 15: 649–650.

    PubMed  CAS  Google Scholar 

  163. Koski SL, Mackey JR, Mackey DS. Myasthenia gravis post allogeneic bone marrow transplantation revisited. Bone Marrow Transplant 1998; 22: 403–404.

    Article  PubMed  CAS  Google Scholar 

  164. Mackey JR, Desai S, Larratt L, Cwik V, Nabholtz JM. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 1997; 19: 939–942.

    Article  PubMed  CAS  Google Scholar 

  165. Porrata LF, Litzow MR, Markovic SN. Immune reconstitution after autologous hematopoietic stem cell transplantation. Mayo Clin Proc 2001; 76: 407–412.

    PubMed  CAS  Google Scholar 

  166. Schuchert MJ, Wright RD, Colson YL. Characterization of a newly discovered T-cell receptor b-chain heterodimer expressed on a CD8+ bone marrow subpopulation that promotes allogeneic stem cell engraftment. Nature Med 2000; 6: 904–609.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Hendrikus G. J. Krouwer MD,PHD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eelco F. M. Wijdicks MD,PHD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, University of Virginia Medical Center, Charlottesville, VA, USA

    David Schiff MD

  2. Center for Neuro-Oncology Dana-Farber Cancer Institute; and Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Patrick Y. Wen MD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Krouwer, H.G.J., Wijdicks, E.F.M. (2003). Neurologic Complications of Hematopoietic Stem Cell Transplantation. In: Schiff, D., Wen, P.Y. (eds) Cancer Neurology in Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-317-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-317-0_17

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4703-4

  • Online ISBN: 978-1-59259-317-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation